258 related articles for article (PubMed ID: 34407676)
1. Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia.
Champlin G; Hwang SN; Heitzer A; Ding J; Jacola L; Estepp JH; Wang W; Ataga KI; Owens CL; Newman J; King AA; Davis R; Kang G; Hankins JS
Exp Biol Med (Maywood); 2021 Dec; 246(23):2473-2479. PubMed ID: 34407676
[TBL] [Abstract][Full Text] [Related]
2. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
[TBL] [Abstract][Full Text] [Related]
3. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
Ware RE; Davis BR; Schultz WH; Brown RC; Aygun B; Sarnaik S; Odame I; Fuh B; George A; Owen W; Luchtman-Jones L; Rogers ZR; Hilliard L; Gauger C; Piccone C; Lee MT; Kwiatkowski JL; Jackson S; Miller ST; Roberts C; Heeney MM; Kalfa TA; Nelson S; Imran H; Nottage K; Alvarez O; Rhodes M; Thompson AA; Rothman JA; Helton KJ; Roberts D; Coleman J; Bonner MJ; Kutlar A; Patel N; Wood J; Piller L; Wei P; Luden J; Mortier NA; Stuber SE; Luban NLC; Cohen AR; Pressel S; Adams RJ
Lancet; 2016 Feb; 387(10019):661-670. PubMed ID: 26670617
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.
Helton KJ; Adams RJ; Kesler KL; Lockhart A; Aygun B; Driscoll C; Heeney MM; Jackson SM; Krishnamurti L; Miller ST; Sarnaik SA; Schultz WH; Ware RE;
Blood; 2014 Aug; 124(6):891-8. PubMed ID: 24914136
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin PM; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
[TBL] [Abstract][Full Text] [Related]
6. Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
Rankine-Mullings A; Reid M; Soares D; Taylor-Bryan C; Wisdom-Phipps M; Aldred K; Latham T; Schultz WH; Knight-Madden J; Badaloo A; Lane A; Adams RJ; Ware RE
Br J Haematol; 2021 Nov; 195(4):612-620. PubMed ID: 34291449
[TBL] [Abstract][Full Text] [Related]
7. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.
Sheehan VA; Hansbury EN; Smeltzer MP; Fortner G; McCarville MB; Aygun B
Pediatr Blood Cancer; 2013 Sep; 60(9):1499-502. PubMed ID: 23625812
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.
Bishop S; Matheus MG; Abboud MR; Cane ID; Adams RJ; Jackson SM; Kalpatthi R
Blood Cells Mol Dis; 2011 Aug; 47(2):125-8. PubMed ID: 21724428
[TBL] [Abstract][Full Text] [Related]
9. Cerebral Infarcts and Vasculopathy in Tanzanian Children With Sickle Cell Anemia.
Jacob M; Saunders DE; Sangeda RZ; Ahmed M; Tutuba H; Kussaga F; Musa B; Mmbando B; Slee AE; Kawadler JM; Makani J; Kirkham FJ
Pediatr Neurol; 2020 Jun; 107():64-70. PubMed ID: 32111561
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.
Rigano P; Pecoraro A; Calvaruso G; Steinberg MH; Iannello S; Maggio A
Am J Hematol; 2013 Nov; 88(11):E261-4. PubMed ID: 23828131
[TBL] [Abstract][Full Text] [Related]
11. The role of MRA in pediatric sickle cell disease with normal transcranial Doppler imaging velocities.
Alshehri E; Dmytriw AA; Chavhan GB; Amirabadi A; Shroff MM; Williams S; Muthusami P
J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104864. PubMed ID: 32402717
[TBL] [Abstract][Full Text] [Related]
12. Practice patterns of stroke screening and hydroxyurea use in children with sickle cell disease: a survey of health care providers.
Madden NA; Jones GL; Kalpatthi R; Woods G
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e382-6. PubMed ID: 24714503
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea or chronic exchange transfusions in patients with sickle cell disease: role of transcranial Doppler ultrasound in stroke prophylaxis.
Suliman H; Wali Y; Al Saadoon M; Zechariah M; William RR; Gujjar A; Pathare A
J Pediatr Hematol Oncol; 2009 Jan; 31(1):42-4. PubMed ID: 19125086
[TBL] [Abstract][Full Text] [Related]
14. Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study.
Green NS; Munube D; Bangirana P; Buluma LR; Kebirungi B; Opoka R; Mupere E; Kasirye P; Kiguli S; Birabwa A; Kawooya MS; Lubowa SK; Sekibira R; Kayongo E; Hume H; Elkind M; Peng W; Li G; Rosano C; LaRussa P; Minja FJ; Boehme A; Idro R
BMC Pediatr; 2019 Oct; 19(1):381. PubMed ID: 31651270
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial.
Ambrose EE; Latham TS; Songoro P; Charles M; Lane AC; Stuber SE; Makubi AN; Ware RE; Smart LR
Lancet Haematol; 2023 Apr; 10(4):e261-e271. PubMed ID: 36870358
[TBL] [Abstract][Full Text] [Related]
16. Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample.
Idro R; Boehme AK; Kawooya M; Lubowa SK; Munube D; Bangirana P; Opoka R; Mupere E; Lignelli A; Kasirye P; Green NS; Minja FJ
J Stroke Cerebrovasc Dis; 2022 Apr; 31(4):106343. PubMed ID: 35158150
[TBL] [Abstract][Full Text] [Related]
17. Stroke in patients with sickle cell disease.
Webb J; Kwiatkowski JL
Expert Rev Hematol; 2013 Jun; 6(3):301-16. PubMed ID: 23782084
[TBL] [Abstract][Full Text] [Related]
18. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Wang WC; Dwan K
Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
[TBL] [Abstract][Full Text] [Related]
19. The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease.
Buchanan ID; James-Herry A; Osunkwo I
J Pediatr Hematol Oncol; 2013 Oct; 35(7):543-6. PubMed ID: 23211694
[TBL] [Abstract][Full Text] [Related]
20. Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease.
Mack AK; Thompson AA
J Pediatr Health Care; 2017; 31(2):145-154. PubMed ID: 27423528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
